Azitra (AZTR) vs Skye Bioscience (SKYE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Azitra is the larger company by market cap ($8.0 million vs $7.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | AZTR | SKYE |
|---|---|---|
| Share price | $0.132 | $1.68 |
| Market cap | $8.00M | $7.44M |
| 1-day change | 0.00% | +1.82% |
| EPS (TTM) | $-0.28 | $-10.16 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.09 | $14.08 |
| 52-week low | $0.10 | $1.50 |
| Distance from 52-week high | -87.89% | -88.07% |
| Average volume | 1.70M | 89.05K |
| Shares outstanding | 60.60M | 4.43M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
AZTR vs SKYE FAQ
Which is bigger, Azitra or Skye Bioscience?
Azitra (AZTR) is larger, with a market capitalization of $8.00M compared with $7.44M for Skye Bioscience (SKYE).
Are Azitra and Skye Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.